跳至主要内容
临床试验/NCT02270853
NCT02270853Unknown不适用

Incidence of Sleep Apnea Syndrome (SAS) in Patients With Bronchial Carcinoma

RWTH Aachen University6 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2014年4月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
6
主要终点
percent of sleep apnea in patients with bronchial carcinoma

研究概览

简要总结

In this study it will be analyzed how often the sleep apnea syndrome can be observed in patients with newly diagnosed lung cancer with the help of ApneaLink device by ResMed.

详细描述

Determination of the SAS- frequence in patients with bronchial carcinoma. The patients will be screened at home for 1 night with the ApneaLink device by ResMed. The apneaLink device is a standard screening tool for sleep apnea in clinical practice.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with reasonable suspicion of bronchial carcinoma or histologically proven bronchial carcinoma, which has not been medicated until the study entry and
  • Patients with sleep apnea who had recently been diagnosed with bronchial carcinoma.

排除标准

  • Pregnancy
  • other already known malignancies or tumors
  • Patients with non-invasive artificial respiration due to a chronic respiratory insufficiencies

结局指标

主要结局

percent of sleep apnea in patients with bronchial carcinoma

时间窗: two days

The percent of sleep apnea in a cohort of patients with bronchial carcinoma will be evaluated. The duration of the study participation is two days.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验